GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
- First anthrax vaccine developed using recombinant DNA technology - Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global...
Binance Becomes First Crypto Exchange To Secure a Global License Under ADGM Framework, Setting a New Standard in Digital-Asset Regulation
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Binance, the world's largest cryptocurrency exchange by trading volume and users, today announced a landmark regulatory achievement: The Financial Services Regulatory Authority (FSRA) of ADGM, the...
IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea
Potential new treatment option for multiple myeloma patients in Korea. Expanded patient access through competitive pricing. SHANGHAI and NANJING, China and PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- Nanjing IASO Biotechnology ("IASO Bio"),...